A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
about
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?The potential of sunitinib as a therapy in ovarian cancer.[Progress of platelet derived grow factor family in non-small cell lung cancer].
P2860
A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A phase I dose-escalation and ...... in non-small cell lung cancer
@ast
A phase I dose-escalation and ...... in non-small cell lung cancer
@en
type
label
A phase I dose-escalation and ...... in non-small cell lung cancer
@ast
A phase I dose-escalation and ...... in non-small cell lung cancer
@en
prefLabel
A phase I dose-escalation and ...... in non-small cell lung cancer
@ast
A phase I dose-escalation and ...... in non-small cell lung cancer
@en
P2093
P2860
P1476
A phase I dose-escalation and ...... in non-small cell lung cancer
@en
P2093
D J Jonker
D R Camidge
L Q M Chow
M McWilliam
P2860
P2888
P304
P356
10.1007/S00280-011-1755-0
P577
2011-10-12T00:00:00Z
P5875
P6179
1013997623